96 related articles for article (PubMed ID: 1093294)
21. Proceedings: The action of subcutaneous and intravenous Corynebacterium parvum on the "lymphocyte trap".
Hamilton DN; Brady E
Br J Surg; 1975 Feb; 62(2):156. PubMed ID: 1115893
[No Abstract] [Full Text] [Related]
22. [Study of anaerobic corynebacteria isolated from 9 000 hemocultures].
Duborgel S
Ann Biol Clin (Paris); 1974; 32(6):487-91. PubMed ID: 4619759
[No Abstract] [Full Text] [Related]
23. Experimental antitumor activity and preclinical toxicology of mycophenolic acid.
Sweeney MJ; Gerzon K; Harris PN; Holmes RE; Poore GA; Williams RH
Cancer Res; 1972 Sep; 32(9):1795-802. PubMed ID: 4509039
[No Abstract] [Full Text] [Related]
24. Experience with the quality control testing of C. parvum suspension for clinical trial.
Knight PA; Lucken RN
Dev Biol Stand; 1977 Apr 13-15; 38():51-8. PubMed ID: 608544
[TBL] [Abstract][Full Text] [Related]
25. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppression of marrow B lymphocytes by administration of Corynebacterium parvum in mice.
Jyonouchi H; Kincade PW; Good RA
J Immunol; 1981 Dec; 127(6):2502-7. PubMed ID: 6457877
[No Abstract] [Full Text] [Related]
27. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
28. Intravenous administration of MIP-1alpha with intra-tumor injection of P. acnes shows potent anti-tumor effect.
Nakano A; Yoneyama H; Ueha S; Kitabatake M; Ishikawa S; Kawase I; Sugiyama H; Matsushima K
Int Immunopharmacol; 2007 Jun; 7(6):845-57. PubMed ID: 17466918
[TBL] [Abstract][Full Text] [Related]
29. Propionibacterium, Corynebacterium, Mycobacterium and Lepra bacilli.
Barksdale L; Kim KS
Acta Leprol; 1984; 2(2-4):153-74. PubMed ID: 6398580
[TBL] [Abstract][Full Text] [Related]
30. [Oncogenicity of gamma-(1-methyl-5-bis-(beta-chloroethyl)-aminobenzimidazolyl-(2))-butyric acid hydrochloride (cytostasan) in mice (author's transl)].
Güttner J; Bruns G; Jungstand W
Arch Geschwulstforsch; 1974; 43(1):16-21. PubMed ID: 4849293
[No Abstract] [Full Text] [Related]
31. The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth.
Fisher B; Rubin H; Saffer E; Wolmark N
Cancer Res; 1976 Aug; 36(8):2714-9. PubMed ID: 1277181
[TBL] [Abstract][Full Text] [Related]
32. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
33. Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma.
Sava G; Pacor S; Ceschia V; Zassinovich G; Mestroni G
Anticancer Res; 1989; 9(3):787-90. PubMed ID: 2764524
[TBL] [Abstract][Full Text] [Related]
34. Proceedings: Combined surgery and Corynebacterium parvum for treatment of metastasizing tumour in mice.
Castro JE; Sadler TE
Br J Surg; 1975 Feb; 62(2):156. PubMed ID: 1115892
[No Abstract] [Full Text] [Related]
35. Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum.
Milas L; Hunter B; Mason K; Grdina D; Withers H
J Natl Cancer Inst; 1975 Apr; 54(4):895-902. PubMed ID: 1127718
[TBL] [Abstract][Full Text] [Related]
36. Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.
Howell LE; Kreider JW; Bartlett GL
J Natl Cancer Inst; 1986 Jul; 77(1):187-93. PubMed ID: 3487670
[TBL] [Abstract][Full Text] [Related]
37. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide--VIII.
Fisher B; Gebhardt MC; Saffer EA
Int J Radiat Oncol Biol Phys; 1978; 4(11-12):975-82. PubMed ID: 721660
[No Abstract] [Full Text] [Related]
38. [Immunotherapy of cancer, using anaerobic corynebacteria].
Halpern B
Acquis Med Recent; 1972; ():95-113. PubMed ID: 4542887
[No Abstract] [Full Text] [Related]
39. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
Naito K; Pellis NR; Kahan BD
Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
[TBL] [Abstract][Full Text] [Related]
40. Alternation of chemotherapy and radiotherapy in cancer management. III. Results in experimental solid tumor systems and their relationship to clinical studies.
Looney WB; Hopkins HA
Cancer Treat Rep; 1986 Jan; 70(1):141-62. PubMed ID: 3002620
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
